NCDs cost India equivalent of 12.5% of its GDP

September 23, 2013
Ankur Sohanpal

According to a report by UCL School of Pharmacy, India is the largest exporter of generic medicines, yet, it lacks free access to good quality generic medicines for its population. According to the same report, spending due to NCDs amount to 12.5% of India’s GDP. Read more here.



View Our Publications

Case Studies, Learnings and More!

View Publications


Footer Image

Get In Touch